Navigation Links
Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
Date:12/28/2010

SAN DIEGO, Dec. 28, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that data from the Company's Matrix Phase 2b clinical study has been accepted for publication in the journal, Wound Repair and Regeneration and provided an update on plans for commercialization of its Excellagen formulated collagen topical wound dressing.  

(Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

The clinical paper now accepted for publication is titled, "Formulated Collagen Gel Accelerates Healing Rate Immediately after Application in Patients with Diabetic Neuropathic Foot Ulcers", and was authored by nine investigators who participated in the Matrix study and Cardium researchers and is expected to be published in early 2011.  Excellagen formulated collagen topical gel wound care dressing was studied in a controlled, double blind Matrix Phase 2b clinical study of chronic diabetic lower extremity ulcers.  Wounds treated with the Excellagen formulated collagen (2.6%) topical gel showed a statistically significant acceleration of wound healing during the first week following a one-time application compared to patients receiving standard of care therapy, a response that was sustained over a 14 day period.  The authors suggest that more frequent applications of Cardium's Excellagen product candidate hold promise to significantly improve overall incidence of complete wound closure.

The Company also provided an update with respect to planned commercialization of its Excellagen topical gel wound care dressing, which comprises a specially formulated collagen matrix gel being produced under a supply agreement with Devro Medical Limited, part of Devro PLC, a public limited company registered in Scotland.  Certain changes to the manufacturing process fo
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments
2. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
3. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
4. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
5. Cardium Regains Listing Compliance With NYSE Amex
6. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
7. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
8. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
9. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
10. Cardium Completes $6.0 Million Registered Direct Offering
11. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... The Brain & Behavior Research ... annual Klerman and Freedman Prizes, recognizing exceptional clinical ... supported by NARSAD Young Investigator Grants. The grants ... in neurobiological and psychosocial research, garner pilot data ... detection, treatment, prevention and cure of mental illnesses. ...
(Date:7/25/2015)... ... July 25, 2015 , ... ... series. It precisely checks and adjusts the surface temperature of the measuring prism. ... the pharmaceutical industry, data traceability and documentation are key requirements. It is likely ...
(Date:7/24/2015)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) will ... 2015 on Thursday, August 6 before the market opens. ... and discuss the financial results in a live webcast ... a.m. Pacific Time). The live call may ... or (847) 413-3238 (international), participant code 40327229. The webcast ...
(Date:7/23/2015)... 23, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: ... for the second quarter 2015 on Thursday, August 6, 2015. ... webcast on that day at 5:00 pm ET to discuss ... update. The call will be hosted by Andrew Gengos ... , , LIVE CALL: , , ,  (877) ...
Breaking Biology Technology:Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6It’s T-Time for Refractometers: On-site Temperature Check Now Available 2ImmunoCellular Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015 2
... Improves Physician Efficiency and Reduces Duplicative and Unnecessary ... ... Nov. 26 RSNA Booth #5924 -- Compressus Inc.,and Advanced ... announced today that ARC has improved physician,efficiency and patient safety, ...
... $5.2 Million ... for Q3 of 2006, -- Gross profit increases 102% to $2.6 Million for Q3 of ... Million for Q3 ... Equity, BEIJING, Nov. 23 /Xinhua-PRNewswire/ -- China Biopharmaceuticals,Holdings, Inc. (OTC Bulletin Board: CHBP), a ...
... PARIS, Nov. 23 Bristol-,Myers Squibb Company (NYSE: ... today,that they are terminating their license agreement for ... for the treatment of,advanced or metastatic bladder cancer ... Fabre Medicament and licensed to Bristol-Myers Squibb,in 2004 ...
Cached Biology Technology:Diagnostic Turnaround Improved by 600% Through Interoperability 2Diagnostic Turnaround Improved by 600% Through Interoperability 3Diagnostic Turnaround Improved by 600% Through Interoperability 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 2China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 3China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 5China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 6China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 7
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... market announces a revised version of one of its first 30 ... on CNBC in New York , ... San Francisco metro areas.    , ... to replace all the cards in your wallet and keep your ...
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2
... ,Western scrub jays summon others to screech over the body ... University of California, Davis. The birds, cacophonous "funerals" can last ... suggested that other animals, including elephants, chimpanzees and birds in ... Teresa Iglesias, the UC Davis graduate student who carried out ...
... Researchers have created a new type of miniature pump activated ... powered by fermentation., The micropump contains bakers yeast and sugar ... patch is placed on the skin, the body heat and ... generating a small amount of carbon dioxide gas. The gas ...
... reactors has the promise to be safe, sustainable and limitless. ... to the commercial energy market. This is partly because the ... A team of researchers at the University of Tennessee, Knoxville, ... institutions, is trying to change that. Led by Brian ...
Cached Biology News:Scrub jays react to their dead 2Body heat, fermentation drive new drug-delivery 'micropump' 2University of Tennessee, ORNL lead national team to study nuclear fusion reactors 2University of Tennessee, ORNL lead national team to study nuclear fusion reactors 3
... System Chemistry Analyzer for General Chemistries, Specialty Chemistries, QC, Reagent Development, Pharmaceutical Development, Physician Owned ... over 30 user-selectable wavelengths. ... ... ...
... for Mac OS X provides the most ... protein sequence analysis and molecular biology data ... Vector NTI Suite you can store manage ... types of molecular biology data all within ...
... Multiple solvents can be used, such as water, benzene, formamide, nitrobenzene, cyclohexane, 1,4-dioxane, p-xylene, dimethyl ... * Range: 12-position switchable: ... ... ...
rat Leptin...
Biology Products: